Guangdong Hybribio Biotech Co., Ltd. Founded in 2009, the company specializes in the research, development, and production of molecular diagnostic reagents and instruments. Headquartered in the Guangdong province of China, the company operates in a modern facility that covers an area of over 10,000 square meters.

The headquarters houses state-of-the-art laboratories, manufacturing facilities, as well as administrative and business offices. The company's commitment to quality and innovation is reflected in its ISO 9001 and ISO 13485 certifications. Guangdong Hybribio Biotech offers a wide range of products and services in the field of molecular diagnostics.

Their main products include diagnostic kits for various infectious diseases such as respiratory infections, sexually transmitted infections, and gastrointestinal infections. The company also provides instruments and automated systems for nucleic acid extraction and amplification. On a global scale, Guangdong Hybribio Biotech has established a strong presence through strategic partnerships, subsidiaries, and joint ventures.

They have collaborated with leading international companies in the field of molecular diagnostics, which has helped expand their global reach and enhance their product portfolio. In terms of market position, Guangdong Hybribio Biotech has gained recognition for its quality products and advanced technologies. They have a strong customer base both domestically and internationally and have achieved significant sales growth.

The company continually strives to maintain its competitive edge by investing in research and development, expanding its product lines, and forging new partnerships to meet the ever-evolving demands of the global healthcare market. In recent years, Guangdong Hybribio Biotech has been actively involved in initiatives related to the COVID-19 pandemic. They have developed rapid diagnostic test kits for COVID-19 and contributed to the global efforts to control the spread of the virus.

Currently, the company continues to expand its market share and remain at the forefront of molecular diagnostics. They are focused on developing innovative solutions and delivering reliable products to assist healthcare professionals in diagnosing and treating various diseases. In summary, Guangdong Hybribio Biotech is a reputable biotechnology company from China that excels in the field of molecular diagnostics.

With a strong market position and a commitment to innovation, they continue to play a vital role in advancing healthcare globally